Summary.-A new, stable platinum coordination complex (FLAP) containing the 5-nitroimidazole, metronidazole, has been prepared and characterized. The squareplanar platinum(II) complex has two metronidazole molecules and two chlorine atoms in the cis configuration. The properties of FLAP differ significantly from metronidazole alone or other platinum complexes tested in the same system. It has a low toxicity towards Chinese hamster ovary cells and is a very effective radiosensitizer toward hypoxic cells in vitro: a one-h pretreatment with a non-toxic dose of 50 ytM gave an enhancement ratio of 2-4. No potentiation of aerated cells to Xirradiation damage was observed after a similar schedule of pretreatment at the higher dose of 100 /uM FLAP.
THE ACHIEVEMENT of local control in the radiotherapy of tumours is often limited by regions of radioresistant but viable hypoxic cells. Hence there has been great interest in chemotherapeutic agents which can sensitize hypoxic tumour cells to ionizing radiation. Our aim was to design a new radiosensitizer, incorporating features of existing agents in a single compound. A combination of platinum and metronidazole, a nitroimidazole was chosen.
Cis-dichloro-diammine platinum(II) (Neoplatin) (Fig. la) is a potent antitumour agent now used in the clinic, but which also acts as a radiosensitizer both in mammalian and bacterial systems (Richmond et al., 1977; Douple & Richmond, 1978) . Another platinum(IJ) complex, cisdichloro -bis(cyclopentylamine)platinum- (II) potentiates damage due to X-rays in aerated Chinese hamster ovary (CHO) cells (Szumiel & Nias, 1976) and the platinum(TV) complex cis-dichloro-bis(isopropylamine)trans-dihydroxy platinum(JV) Correspondlence to Professor A. H. Mr. Nias.
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(CHIP), exhibits potentiation of X-ray damage under hypoxic conditions (Laverick & Nias, 1981) . Nitroheterocycles have also been widely studied as hypoxic cell radiosensitizers on account of the high electron affinity of the nitro group (Adams et al., 1978; Willson, 1977) . Thus, metronidazole or Flagyl (1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole) (Fig. lb) has undergone clinical trials (Urtasun et al., 1978) . Metronidazole is also preferentially cytotoxic to hypoxic cells and hence is widely used in the treatment of anaerobic bacterial infections (Edwards et al., 1973) .
Since the nitrogen at the 3-position of metronidazole bears a lone pair of electrons, it was decided to attempt the synthesis of a complex of the type, Pt(Tl)-(metronidazole)2CI2 (Fig. lc) , preferably with the chloride ligands in the cis configuration. It was hoped that, as the complex was neutral, it would readily pass through cell membranes. As in the case of Neoplatin, it has 2 potentially reactive cis (Szumiel & Nias, 1976; Nias et al., 1979 In all experiments the cells were exposed to the drugs for 1 h at 37°C under aerated conditions. The medium containing the drug was then removed and replaced by fresh medium. This was followed 1 h later by X-irradiation in air or in hypoxia.
Irradiation.-X-rays of 250 kV were produced from a Maximar unit (HVL = 0-83 mm Cu) and the dose rate was 1-75 Gy min-1. Dose-response curves.-The data points are shown as mean survival (from at least 2 experiments per point) + the s.e. of the mean. The exponential slope of each curve was fitted to the data points by linear regression. This exponential slope is used to describe the mean lethal dose (Do) of drug or X-ray. Do is the dose required to reduce the surviving fraction by a factor of l/e (0 37) along the exponential portion of the curve.
RESULTS AND DISCUSSION
The toxicity of FLAP was tested in terms of the clonogenic survival of CHO cells and compared with CHIP and Neoplatin in the same system (Fig. 2) . The dose-response curve constructed for FLAP is typical of other platinum coordination complexes, having a "shoulder" region followed by an exponential dose-response to cell killing at the higher doses. In terms of molarity FLAP (Do = 90 ,uM) is far less toxic to CHO cells than CHIP (Do = 10 ,uM), which is itself less toxic than Neoplatin (Do= 3 EM). In our system metronidazole is completely non-toxic up to a concentration of 5 mM. The toxicity of Neoplatin toward tumour cells is thought to be related to its ability to cause irreparable lesions on DNA, probably via inter-or intra-strand cross-links between guanine or cytosine bases (Zwelling & Kohn, 1980) . The reactive cis chloride "leaving groups" are thought to be involved in this cross- The capacity of FLAP to potentiate Xirradiation damage was compared with metronidazole and CHIP using a 1-h delay between drug and irradiation treatments (Fig. 3) . CHO Enhancement of the radiation response of hypoxic cells due to drug pretreatment of the cells is shown in Fig. 3 by a decrease in the final slope (Do) of the combined modality dose response curves. This effect is measured as an enhancement ratio (ER). Because the extrapolation numbers (n) are not significantly different, this enhancement ratio is a true dose-modifying factor, and sensitization is observed even at low X-ray doses on the "shoulder" of the combined modality curves.
The ER observed after pretreating cells with 500 ,uM metronidazole was 1-5. However, even with a 10 x lower concentration of FLAP (50 ,uM), a far greater potentiation of X-ray cell killing was achieved, with an ER of 2-4. This result can also be compared with that obtained after the slightly higher dose, 70 [kM, of the platinum(IV) complex, CHIP. Pretreatment with CHIP gave an ER of 1-5. At this high dose, CHIP is toxic to CHO cells and the combined modality curve has been normalized with respect to CHIP toxicity. Finally, we examined the combined effect of FLAP pretreatment and X-irradiation of CHO cells in air using a dose of 100 luM FLAP. No enhancement of the radiation response of aerated cells was observed (i.e. ER = 10) with this higher concentration of FLAP. The OER of these cells is 2-8. Further experiments would be required to determine how metronidazole transport into cells is affected by being part of a platinum complex. The high level of potentiation to X-ray cell killing may arise, not only from DNA targeting via the cis dichloride system, but also from the synergism of the 2 types of electron affinic centres in the FLAP molecule (Pt(II) and NO2 groups). However it is evident from the change in halfwave potential (E l) that the nitro group is perturbed when metronidazole is bound to platinum; and thus the properties of bound metronidazole will differ from those of free metronidazole.
In conclusion FLAP has been shown to be very effective radiosensitizer of hypoxic cells in vitro at a non-toxic dose. Its effect, producing an ER of 2-4, is far greater than could have been predicted from results obained for metronidazole or other platinum complexes tested so far in this system. Also, at the higher dose used, no corresponding sensitization of aerated cells was observed. Work is now in progress to test the effectiveness of this complex as a radiosensitizer in vivo.
